Surgery Partners, Inc. (NASDAQ: SGRY) had its price target lowered by analysts at Royal Bank of Canada from $49.00 to $35.00. They now have an "outperform" rating on the stock.
Surgery Partners, Inc. (NASDAQ: SGRY) had its "outperform" rating re-affirmed by analysts at Macquarie. They now have a $34.00 price target on the stock.
Surgery Partners, Inc. (NASDAQ: SGRY) had its price target lowered by analysts at Macquarie from $35.00 to $34.00. They now have an "outperform" rating on the stock.
Surgery Partners Inc (SGRY) Q3 2024 Earnings Call Highlights: Robust Revenue Growth and ... [Yahoo! Finance]
Surgery Partners, Inc. Announces Third Quarter 2024 Results